Valeant Pharmaceuticals Inc. (NYSE: VRX) signed a twenty year deal to supply Walgreens Boots Alliance Inc. (Nasdaq: WBA) with its products at discounted prices. Shares of Valeant leaped $15.31 to $109.45 while Walgreens stock edged up 24 cents to $82.80.
Valeant signs 20 year deal with Walgreens
December 15, 2015 at 12:13 PM EST
